Topical Antiparasitic Agents

  • Pregnancy Category B
  • Organic compound, derived from flowers of Compositae
Formulations and Dosage
  • 0.33 % lotion and shampoo

Head lice

  • Apply to clean, dry hair for 10 min before washing (important that hair is dry or can become diluted)
Mechanism of Action
  • Inhibits closure of voltage-gated Sodium channels inhibiting repolarization and paralyzing the mite, leading to its death
Indications

FDA

  • Head lice
Side Effects
  • Irritation
  • Since derived from flowers of Compositae, can cross reacts in patients with ragweed allergy and formaldehyde
Other
  • Combined with piperonyl butoxide (stabilize and increases duration)
  • Pregnancy Category B
Formulations and Dosage
  • Available as 5% cream (used for scabies) and 1% cream (used for pediculosis)

Scabies (Day 1 and Day 8)

  • apply neck down (infants and young children, apply to scalp and face too); leave on overnight and wash off in AM

Head lice

  • Shampoo hair first (no conditioner), towel dry then apply x10 min on days 1 and 8 then rinse out
Mechanism of Action
  • Synthetic Pyrethrin: Inhibits closure of voltage-gated sodium channels inhibiting repolarization and paralyzing the mite, leading to its death
Indications

FDA

  • scabies (age > 2 months)

Other

  • Head lice and pubic lice (pediculosis capitis and pubis)
  • Demodex folliculitis
Side Effects
  • Local: irritation, xerosis, pruritis; mild and transient burning and stinging
  • Not to be used in patients with Compositae allergy due to possibility of cross reaction; also with formaldehyde
Other
  • Greater effectiveness against lice, scabies, and ticks compared to organic pyrethrin
  • 1-2% systemic absorption with 5% cream
  • the following are equivalent in terms of treatment of scabies: permethrin 5%, topical 1% ivermectin, oral ivermectin
  • Resistance reported in scabies and lice with mutations in sodium channels
  • Only 25% are lice free after treatment
  • Pregnancy Category B
Formulations and Dosage
  • 0.5% lotion

Head lice

  • Apply to dry hair then rinse with shampoo after 8-12 hours (some studies show similar efficacy with 20-minute application); may re-treat in 1 week
Mechanism of Action
  • Organophosphate cholinesterase inhibitor converted to malaoxon; irreversibly inhibits acetylcholinesterase leading to neuromuscular paralysis and death
Indications

FDA

  • Head lice (pediculosis capitis)
Side Effects
  • Flammable due to alcohol content, local irritation
  • Toxic if ingested (organophosphate poisoning)
Other
  • Best treatment for head lice
  • Pregnancy Category C
Formulations and Dosage
  • 0.5% lotion; 1% lotion
  • Available in cream format

Scabies

  • 1 application per week, repeat for 4 weeks

Head lice

  • Applied to dry hair for 10 minutes then rinsed with water only (no shampoo or conditioner for 24 hours)
Mechanism of Action
  • Binds GABA-gated chloride channels, leading to increased permeability and hyperpolarization with subsequent paralysis and death of the mite
Indications

FDA

  • Pediculosis capitis (>6 months of age)
  • Rosacea (1% cream applied once a day – presumed to be anti-inflammatory. The exact mechanism is unknown.)

Other

  • Scabies (efficacy equivalent to topical permethrin)
Side Effects
  • Skin irritation and localized burning
Other
  • Can be used during lactation, but must avoid on nipple/areola area
  • Pregnancy Category B
Formulations and Dosage
  • 0.9% solution

Head lice

  • Applied to dry hair then rinsed after 10 min; retreatment in 1 week
Mechanism of Action
  • Excites motor neuron leading to muscle spasm, paralysis and death of the mite
Indications

FDA

  • Pediculosis capitis (> 6 months of age)
Side Effects
  • Skin irritation, erythema
Other
  • Breastfeeding should be avoided for 8 hours after use
  • Pregnancy Category C
Formulations and Dosage
  • 1% shampoo or lotion
Mechanism of Action
  • Organochloride (hydrocarbon) insecticide; inhibits nerve transmission of mite
Indications
  • No longer used (previously used for scabies, lice)
Side Effects
  • neurotoxicity, seizures
  • heme: aplastic anemia, leukemia
Other
  • Banned in most countries
  • Pregnancy Category C
Formulations and Dosage
  • 10% cream or lotion
Mechanism of Action
  • Unknown, mainly anti-pruritic only and minimally effective for scabies
Indications

FDA

  • Scabies
Side Effects
  • * For further reading/information refer to a pharmacology source
Other
  • Apply neck down for 2 consecutive days
  • Pregnancy Category N/A
Formulations and Dosage
  • 10-25% solution (compounded solution)
  • Scabies: apply BID for 3 days; can be combined with oral ivermectin (single dose)
Mechanism of Action
  • * For further reading/information refer to a pharmacology source
Indications
  • Used in scabies
Side Effects
  • Skin irritation
  • Avoid EtOH for 48 hrs; causes disulfiram like reaction
Other
  • Most common treatment for scabies in developing world due to cost-effectiveness
  • Pregnancy Category N/A
Formulations and Dosage
  • 5-10% (compounded in cream/ointment)
Mechanism of Action
  • Antiseborrhiec, antiparasitic and keratolytic
Indications
  • Used in scabies: applied for 24 hrs than washed off, repeat daily x 5 days total
Side Effects
  • Odor and mild skin irritation
Other
  • Mentioned to be treatment of choice for scabies in pregnancy however no studies available to support this
  • Pregnancy Category N/A
Formulations and Dosage
  • 5% oil
Mechanism of Action
  • Melaleuca alternifolia oil leads to death of mites within 3 hours; also, anti-pruritic
Indications
  • Used in scabies
Side Effects
  • Allergic contact dermatitis, and can also act as a sensitizer
Other
  • Can be an option for select patients
  • Pregnancy Category C
Formulations and Dosage
  • 10% lipophilic ointment (compounded)
  • To be applied under occlusion 3-4 times/day for 5-10 days
Mechanism of Action
  • Binds colchicine sensitive cells of tubulin in helminths leading to death of mite
Indications
  • Cutaneous larva migrans
Side Effects
  • Local irritation and skin ulceration
Other
  • Good option in pregnancy and in young children or if oral ivermectin/albendazole is contraindicated